Imitrex

Rediff.com » News » Imitrex

News for Imitrex

Business

Imitrex delay: Ranbaxy may lose up to Rs 300 cr

Drug major Ranbaxy Laboratories could suffer a potential revenue loss to the tune of Rs 300 crore (Rs 3 billion) due to delay in receiving approval from the US Food and Drug Administration (FDA)......

Glaxo's strategy may limit gains for Indian firms

Global pharma major GlaxoSmithKline's strategy of launching an improved version of the migraine drug, Imitrex, after having an out-of-court settlement with Dr Reddy's and Ranbaxy Laboratories over......

GlaxoSmithKline sues Dr Reddy's

GlaxoSmithKline has filed a lawsuit in a United States court against Dr Reddy's Laboratories alleging infringement of patent rights of a generic version of 'Imitrex' drug, used for the treatment of......

Indian generics profit from Glaxo patent expiry

GlaxoSmithKline Plc's anti-migraine drug brand, Imitrex, is turning out to be a good revenue earner for Indian generic companies, as the US Food and Drug Administration has given almost half of the......

Top Coverage News

World Test Championship 2023

India held the top position in the ICC Men's Test Team Rankings while Australia secured the...

Manipur's Tragedy

Here are news, updates and coverage from violence hit Manipur.

IPL 2023

Complete coverage of IPL 2023

Sri Lanka's Tour of India 2023

Complete Coverage of Indian cricket team's encounter with Sri Lanka during 3rd Jan - 15th Jan 2023.

GUJARAT, HIMACHAL GO TO POLLS

The Bharatiya Janata Party was on Thursday poised for a landslide victory in Gujarat to retain...

Broswe by: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Rediffmail for WorkBook a domainRediffmailMoneyOnline ShoppingVideos